Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Seocalcitol Versus Placebo in Advanced Hepatocellular Carcinoma. Efficacy of Seocalcitol (EB 1089) Enteric-Coated Capsules (5ug) or Placebo in the Treatment of Patients With Hepatocellular Carcinoma Not Amenable to Curative Treatment

NCT00051532 is registered in ClinicalTrials.gov with LEO Pharma as lead sponsor.

NCT NCT00051532
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00051532 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Seocalcitol Versus Placebo in Advanced Hepatocellular Carcinoma. Efficacy of Seocalcitol (EB 1089) Enteric-Coated Capsules (5ug) or Placebo in the Treatment of Patients With Hepatocellular Carcinoma Not Amenable to Curative Treatment
Lead sponsor
LEO Pharma
Phase
Not applicable
Overall status
Terminated
Start date
September 30, 1999
Completion date
May 31, 2004
Enrollment
700
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

liver neoplasms